Cataract disease represents an important health problem that accounts for 22% of all cases of blindness. Over 2 million cataract operations are performed in the US annually. The etiology of cataract disease remains unclear but is clearly multifactorial. Ther heritable predisposition to cataract disease suggest that genetic factors can contribute to the pathogenesis of cataracts. Congenital cataracts whcih manifest as a central (nuclear) opacifications are believed to represent perturbations in normal lens cell differentiation; however, molecular mechanisms governing cataract formation and normal lens differentiation are poorly understood. Myc-family genes (c- N- and L-myc) are believes to play key regulatory roles in normal cell growth and differentiation. Each gene is differentially expressed throughout mammalian development with dramatic changes in the expression of specific myc members coinciding with key developmental transitions in many cell lineages. We ahve demonstrated that as lens fiber cells progress through their developmental program myc-family genes are differentially regulated with respect to developmental stage. For instance, proliferating undifferentiated lens cells express c-myc and L-myc. As these immature cells undergo proliferative arrest and initiate differentiation, both c-myc and L-myc are down-regulated. In contrast, N-myc transcripts are not detectable in immature cells but become abundant at the onset of differentiation. The goal of these studies is to determine the physiological significance of myc in lens differentiation and in the development of cataract disease. To achieve these objectives, we will produce transgenic mice that aberrantly express myc-family genes in the developing lens. With the alphaA-crystallin promoter-enhancer element, we have demonstrated that forced expression of the L-myc gene in differentiating lens cells induces large nuclear congenital cataracts in all cases. Nuclear congenital cataracts may be related to defected lens development and suggests that myc serevs an important role in normal lens cell differentiation. The focus of the proposed studies are (1) to characterize further the structural and molecular features of these alphaA crystallin promoter-driven L-myc transgenic mice, (2) to generate and characterize similar transgenic animals with the c-myc gene, and (3) to utilize dominant interference to abrogate N-myc activity in actively differentiating lens fiber cells, (4) to explore the xpression and function of myc family homologues in the lens of Xenopus laevis.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
1R01EY009300-01
Application #
3266702
Study Section
Visual Sciences A Study Section (VISA)
Project Start
1991-07-01
Project End
1996-06-30
Budget Start
1991-07-01
Budget End
1992-06-30
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
Schools of Medicine
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
de Alboran, I M; O'Hagan, R C; Gartner, F et al. (2001) Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. Immunity 14:45-55
O'Hagan, R C; Schreiber-Agus, N; Chen, K et al. (2000) Gene-target recognition among members of the myc superfamily and implications for oncogenesis. Nat Genet 24:113-9
Bardeesy, N; Wong, K K; DePinho, R A et al. (2000) Animal models of melanoma: recent advances and future prospects. Adv Cancer Res 79:123-56
Malynn, B A; de Alboran, I M; O'Hagan, R C et al. (2000) N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. Genes Dev 14:1390-9
Shen-Li, H; O'Hagan, R C; Hou Jr, H et al. (2000) Essential role for Max in early embryonic growth and development. Genes Dev 14:17-22
Gomez Lahoz, E; Liegeois, N J; Zhang, P et al. (1999) Cyclin D- and E-dependent kinases and the p57(KIP2) inhibitor: cooperative interactions in vivo. Mol Cell Biol 19:353-63
Greenberg, R A; O'Hagan, R C; Deng, H et al. (1999) Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene 18:1219-26
Chin, L; Pomerantz, J; DePinho, R A (1998) The INK4a/ARF tumor suppressor: one gene--two products--two pathways. Trends Biochem Sci 23:291-6
Chin, L; Merlino, G; DePinho, R A (1998) Malignant melanoma: modern black plague and genetic black box. Genes Dev 12:3467-81
Zhang, P; Wong, C; DePinho, R A et al. (1998) Cooperation between the Cdk inhibitors p27(KIP1) and p57(KIP2) in the control of tissue growth and development. Genes Dev 12:3162-7

Showing the most recent 10 out of 22 publications